Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.

Int J Nanomedicine · 2015 · PMC4508085 · PMID 26203246

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

CL treatment of FI-RSV immune mice did not show apparent changes in histopathology probably due to the full-blown severe histopathology, but showed a trend of further increasing inflammation scores to the maximum (FI-RSV + RSV, Figure 7B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.